Sorrento Therapeutics Inc (SRNE): Our chapter 11 process has caused and ma...

Reply Private New

Replies (1) Next 10 Prev Next

Send PM Follow Ignore

Followers	14
Posts	706
Boards Moderated	0
Alias Born	08/21/2012

Brandywhitneylady

Re: Jesspro post# 14784

Thursday, 06/22/2023 6:55:08 PM

Thursday, June 22, 2023 6:55:08 PM

Our chapter 11 process has caused and may continue to cause our common stock and other securities to decrease in value, and may eventually render our common stock or other securities worthless.

Under the prospectus section. They even underlined it for you.

Really can’t find it? Wake up.

Keep Last Read

Replies (1) Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

Detailed Quote

Recent SRNE News

Form 8-K - Current report • Edgar (US Regulatory) • 11/03/2023 09:31:06 PM
Form 8-K - Current report • Edgar (US Regulatory) • 10/27/2023 08:15:31 PM
Form 8-K - Current report • Edgar (US Regulatory) • 09/13/2023 01:51:06 AM
Form 8-K - Current report • Edgar (US Regulatory) • 08/28/2023 09:25:07 PM
Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 08/07/2023 08:15:35 PM
Form 8-K - Current report • Edgar (US Regulatory) • 08/01/2023 10:01:54 AM
Form 8-K - Current report • Edgar (US Regulatory) • 07/13/2023 10:26:26 AM